1. Ka'idodin asali da ka'idodin fasaha na endoscopes multiplex
Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwararren Ƙwaƙwalwa na Ƙaƙwalwa da aka yi da shi shi ne na'urar likita da za a sake amfani da ita wanda ke shiga cikin jikin mutum ta hanyar rami na jikin mutum ko wani ɗan ƙaramin yanki a cikin ƙananan ƙwayar cuta don taimakawa likitoci su gano cututtuka ko taimakawa wajen tiyata. Tsarin endoscope na likita ya ƙunshi sassa uku masu mahimmanci: jikin endoscope, tsarin sarrafa hoto da tsarin tushen haske. Jikin endoscope kuma ya ƙunshi maɓalli masu mahimmanci kamar ruwan tabarau na hoto, firikwensin hoto (CCD ko CMOS), saye da sarrafa da'irori. Daga mahangar tsararrun fasaha, endoscopes masu yawa sun samo asali daga tsayayyen endoscopes zuwa fiber endoscopes zuwa endoscopes na lantarki. Ana yin endoscopes na fiber ta amfani da ka'idar sarrafa fiber na gani. Sun ƙunshi dubun-dubatar filayen filaye na gilashin da aka tsara bisa tsari don samar da katako mai haske, kuma ana watsa hoton ba tare da murdiya ba ta hanyar maimaitawa. Endoscopes na zamani na lantarki suna amfani da na'urori masu auna firikwensin hoto da fasahar sarrafa siginar dijital don haɓaka ingancin hoto da daidaiton bincike.
2. Halin kasuwa na sake amfani da endoscopes
| Girman Category | Tda | MkasuwaSzomo | Magana |
|
Tsarin Samfur" | Endoscopy mai tsanani | 1. Girman kasuwar duniya ya kai dalar Amurka biliyan 7.2.2. Fluorescence hard endoscope shine yanki mafi saurin girma, a hankali yana maye gurbin endoscope na farin haske na gargajiya. | 1. Yankunan aikace-aikacen: tiyata na gabaɗaya, urology, tiyatar thoracic da likitan mata.2. Manyan masana'antun: Karl Storz, Mindray, Olympus, da dai sauransu. |
| Endoscopy mai sassauci | 1. Girman kasuwar duniya ya kai yuan biliyan 33.08. 2. Olympus yana lissafin 60% (filin endoscope mai sassauci). | 1.Gastrointestinal endoscopes lissafin fiye da 70% na m endoscope kasuwar 2. Manyan masana'antun: Olympus, Fuji, sonoscape, Aohua, etc. | |
|
Ka'idar Hoto | Na gani endoscope | 1. Girman kasuwannin duniya na tushen hasken sanyi na endoscopes ya kai yuan biliyan 8.67. 2.0 Kasuwannin kasuwar Lympus ya wuce 25%. | 1. Dangane da ka'idar aikin gani na geometric 2. Ya ƙunshi tsarin ruwan tabarau na haƙiƙa, tsarin watsawa / watsawa na gani, da sauransu. |
|
| Endoscope na lantarki | Tallace-tallacen duniya na babban ma'anar bronchoscopes na lantarki ya kai dalar Amurka miliyan 810. | 1. Dangane da canjin bayanan hoto da hanyoyin sarrafa hoto 2. Ciki har da tsarin lens na haƙiƙa, firikwensin hoto na hoto, da sauransu. |
|
Aikace-aikacen asibiti | Endoscopy na narkewa | Ya mamaye kashi 80% na kasuwar ruwan tabarau mai laushi, wanda Olympus ke da 46.16%. | Alamar gidasonoscape Likitan ya zarce Fuji a kason kasuwa na asibitocin sakandare. |
| Endoscopy na numfashi | Olympus yana da kashi 49.56% na jimlar kason kasuwa na endoscopes na narkewa. | Canjin cikin gida yana haɓaka, kuma Aohua Endoscopy ya girma sosai. | |
| Laparoscopy/Arthroscopy | Thoracoscopy da laparoscopy na lissafin kashi 28.31% na kasuwar endoscopy na kasar Sin. | 1. 4K3D rabon fasaha ya karu da 7.43%. 2. Mindray Medical ya zama na farko a asibitocin sakandare. |
1)Kasuwar duniya: Olympus ya mallaki kasuwa don ruwan tabarau mai laushi (60%), yayin da kasuwar ruwan tabarau mai wuyar gaske ke girma (dalar Amurka biliyan 7.2). Fasaha mai walƙiya da 4K3D sun zama jagorar ƙima.
2)Kasuwar China: Bambance-bambancen yanki: Guangdong yana da mafi girman adadin sayayya, lardunan bakin teku suna mamaye da samfuran shigo da kayayyaki, kuma maye gurbin cikin gida yana haɓaka a yankuna tsakiya da yamma.Ci gaban cikin gida:Matsakaicin adadin ruwan tabarau mai ƙarfi shine 51%, kuma buɗewar ruwan tabarau mai laushi / Ostiraliya da China suna lissafin 21% gabaɗaya. Manufofi suna haɓaka babban canji.Matsakaicin asibiti: Manyan asibitoci sun fi son kayan aikin da aka shigo da su (kashi 65%), kuma asibitocin sakandare sun zama ci gaba ga samfuran gida.
3. Abvantbuwan amfãni da kalubale na sake amfani da endoscopes
| Amfani | Takamaiman bayyanar cututtuka | Tallafin bayanai |
| Fitaccen aikin tattalin arziki | Ana iya sake amfani da na'ura ɗaya sau 50-100, tare da tsadar dogon lokaci da ƙasa da ƙarancin endoscopes da za'a iya zubarwa (farashin amfani ɗaya ne kawai 1/10). | Ɗauki gastroenteroscopy a matsayin misali: farashin siyan siyan endoscope mai sake amfani da shi shine RMB 150,000-300,000 (ana iya amfani da shi don shekaru 3-5), kuma farashin endoscope mai yuwuwa RMB 2,000-5,000. |
| Babban balagaggen fasaha | Fasaha irin su 4K Hoto da AI-taimakon ganewar asali an fi so don yin yawa, tare da tsabtar hoto 30% -50% mafi girma fiye da na amfani da lokaci ɗaya. | A cikin 2024, ƙimar shigar 4K a cikin babban ƙarshen ƙarshen ƙarshen duniya zai kai 45%, kuma ƙimar ayyukan AI-taimakawa zai wuce 25%. |
| Mai ƙarfi na asibiti karbuwa | Jikin madubi an yi shi da wani abu mai ɗorewa (karfe + polymer na likita) kuma ana iya daidaita shi zuwa nau'ikan masu haƙuri daban-daban (kamar madubin bakin ciki na yara da daidaitattun madubai na manya). | Matsakaicin dacewa na ƙaƙƙarfan endoscopes a cikin tiyatar kasusuwa shine 90%, kuma nasarar nasarar endoscopes masu sassauci a cikin gastroenterology ya wuce 95%. |
| Siyasa da kwanciyar hankali sarkar samar da kayayyaki | Kayayyakin da za a sake amfani da su sune na yau da kullun a cikin duniya, kuma tsarin samar da kayayyaki ya balaga (Olympus,sonoscape da sauran kamfanoni suna da tsarin safa na ƙasa da wata 1). | Kayan aikin da za a sake amfani da su sun kai sama da kashi 90% na sayayya a manyan asibitocin kasar Sin, kuma manufofin ba sa hana yin amfani da na'urorin da za a sake amfani da su.. |
| Kalubale | Takamaiman Batutuwa | Tallafin bayanai |
| Tsaftacewa da haɗarin kashe cututtuka | Sake amfani da shi yana buƙatar tsayayyen ƙwayar cuta (dole ne ya bi ka'idodin AAMI ST91), kuma rashin aiki mara kyau na iya haifar da kamuwa da cuta (yawan abin da ya faru 0.03%). | A cikin 2024, FDA ta Amurka ta tuno da endoscopes 3 da za a sake amfani da su saboda gurɓatarwar tsaftacewa. |
| Babban farashin kulawa | Ana buƙatar kulawar ƙwararru (kayan aikin tsaftacewa + aiki) bayan kowane amfani, kuma matsakaicin ƙimar kulawa na shekara-shekara ya kai 15% -20% na farashin siyan.. | Matsakaicin farashin kulawa na shekara-shekara na endoscope mai sassauƙa shine yuan 20,000-50,000, wanda ya kai 100% sama da na na'urar da za a iya zubarwa (ba a kiyayewa). |
| Matsi na maimaitawar fasaha | Fasahar endoscope da za a iya zubarwa ta kama (misali 4K module ɗin farashin ya ragu da 40%), sake amfani da ƙarancin kasuwa. | A shekarar 2024, yawan ci gaban kasuwar endoscope na kasar Sin zai kai kashi 60%, kuma wasu asibitocin da za a iya zubar da su za su fara sayen na'urorin da za a iya zubar da su don maye gurbin endoscopes masu karamin karfi. |
| Ƙa'idoji masu tsauri | EU MDR da FDA ta Amurka suna haɓaka ƙa'idodin sake sarrafawa don sake amfani da endoscopes, haɓaka farashin yarda ga kamfanoni (farashin gwaji ya karu da 20%). | A cikin 2024, adadin dawo da endoscopes da za a sake amfani da shi da aka fitar daga China saboda batutuwan da suka dace zai kai kashi 3.5% (kashi 1.2% a cikin 2023 kawai). |
4.Kasuwa Matsayin da Manyan Manufacturers
Kasuwancin endoscope na duniya na yanzu yana gabatar da halaye masu zuwa:
Tsarin kasuwa:
Alamar ƙasashen waje sun mamaye: Kattai na duniya kamar KARL STORZ da Olympus har yanzu sun mamaye babban kasuwar kasuwa. Ɗaukar hysteroscopes a matsayin misali, manyan martaba uku na tallace-tallace a cikin 2024 duk samfuran waje ne, suna lissafin jimlar 53.05%.
Haɓaka samfuran cikin gida: A cewar bayanan fasaha na Zhongcheng Digital, kason kasuwa na endoscope na cikin gida ya karu daga ƙasa da kashi 10% a shekarar 2019 zuwa kashi 26% a shekarar 2022, tare da matsakaicin girma na shekara-shekara fiye da 60%. Kamfanonin wakilai sun haɗa da Mindray,sonoscape, Aohua, etc.
Mayar da hankali ga gasar fasaha:
Fasahar hoto: 4K ƙuduri, CMOS firikwensin maye gurbin CCD, zurfin EDOF na fasahar fadada filin, da dai sauransu.
Zane na Modular: Ƙirar binciken da za a iya maye gurbinsa yana ƙara rayuwar sabis na ainihin abubuwan haɗin gwiwa.
Tsaftacewa mai hankali: Sabon tsarin tsaftacewa wanda ya haɗu da ganewar gani na AI tare da ɗimbin ɗimbin yawa na ma'aikatan tsaftacewa masu yawa-enzyme.
| Matsayi
| Alamar | Kasuwar China | Manyan Yankunan Kasuwanci | Fa'idodin fasaha da aikin kasuwa |
| 1 | Olympus | 46.16% | Ƙimar endoscopes masu sassauƙa (70% a cikin ilimin gastroenterology), endoscopy, da tsarin bincike na AI.. | Fasahar hoto ta 4K tana da kaso sama da kashi 60 cikin 100 na kasuwannin duniya, manyan asibitocin kasar Sin sun kai kashi 46.16 cikin dari na sayayya, kuma masana'antar Suzhou ta samu nasarar samar da kayayyaki a gida.. |
| 2 | Fujifilm | 19.03% | Endoscope mai sassauƙa (fasaharar hoton laser shuɗi), endoscope na numfashi mai tsananin bakin ciki (4-5mm). | Kasuwar ruwan tabarau mafi girma ta biyu mafi girma a duniya, kasuwar babban asibiti ta kasar Sin ta zarce ta Sonoscape Medical, kuma kudaden shiga a shekarar 2024 zai ragu da kashi 3.2% a duk shekara.. |
| 3 | Karl Storz | 12.5% | Riged endoscope (Laparoscopy asusun don 45%), Fasahar 3D CLOORILESNE, Exoscope. | Kasuwar endoscope mai ƙarfi ita ce ta farko a duniya. An amince da kayayyakin da ake samarwa a cikin gida na ginin masana'antar Shanghai. Sabbin sayayya na 3D fluorescent laparoscopes lissafin 45%. |
| 4 | Sonoscape likita | 14.94% | Endoscope mai sassauci (endoscope na Ultrasound), tsarin gano polyp AI, tsarin endoscope mai tsauri. | Kamfanin yana matsayi na hudu a kasuwar ruwan tabarau mai laushi ta kasar Sin, tare da manyan asibitocin da ke da kashi 30% na sayayyar kayayyakin 4K+AI, kuma kudaden shiga ya karu da kashi 23.7% a shekara a 2024.. |
| 5 | HOYA(Pentax Medical) | 5.17% | Endoscope mai sassauƙa (gastroenteroscopy), m endoscope (otolaryngology). | Bayan da HOYA ta samu, tasirin haɗin gwiwar ya iyakance, kuma kasuwarta a kasar Sin ta fadi daga cikin goma na farko. Kudaden shiganta a cikin 2024 sun faɗi da kashi 11% kowace shekara. |
| 6 | Aohua Endoscopy | 4.12% | Endoscopy mai sassauci (gastroenterology), babban endoscopy. | Babban rabon kasuwa a farkon rabin na 2024 shine 4.12% (mai laushi mai laushi + endoscope mai wuya), kuma ribar ribar babban ƙarshen endoscopes zai karu da 361%. |
| 7 | Mindray Medical | 7.0% | Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙarƙashin Ƙaƙwalwar Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararru na 12.57%). | Kasar Sin tana matsayi na uku a cikin kasuwar endoscope mai wuya, tare da asibitocin gundumomi'haɓakar sayayya ya wuce 30%, kuma rabon kudaden shiga na ketare yana ƙaruwa zuwa 38% a 2024. |
| 8 | Optomedic | 4.0% | Fluoroscope (Urology, Gynecology), madadin gida. | Kasuwar kasar Sin na lens mai tsananin kyalli ya zarce kashi 40 cikin dari, kayayyakin da ake fitarwa zuwa kudu maso gabashin Asiya ya karu da kashi 35%, jarin R&D ya kai kashi 22%. |
| 9 | Styker | 3.0% | Neurosurgery m endoscope, urology tsarin kewayawa fluorescent, arthroscope. | Kasuwar kasuwa na neuroendoscopes ya zarce 30%, kuma yawan siyan ci gaban asibitocin gundumomi a China shine 18%. Mindray Medical ne ya matse kasuwar ƙasa. |
| 10 | Sauran Alamomin | 2.37% | Alamar yanki (kamar Rudolf, Toshiba Medical), takamaiman sassa (kamar madubin ENT). |
5.Core fasaha ci gaban
1)Narrow-band Hoto (NBI): kunkuntar-band Hoto hanya ce ta ci gaba ta dijital wacce ke haɓaka hangen nesa na sifofin mucosal da tsarin microvascular ta hanyar amfani da takamaiman tsayin igiyoyin shuɗi-kore. Nazarin asibiti ya nuna cewa NBI ta haɓaka daidaitattun cututtukan cututtukan cututtukan ciki da maki 11 (94% vs 83%). A cikin ganewar asali na metaplasia na hanji, hankali ya karu daga 53% zuwa 87% (P <0.001). Ya zama kayan aiki mai mahimmanci don gwajin ciwon daji na ciki na farko, wanda zai iya taimakawa wajen bambance raunuka masu kyau da marasa kyau, biopsy da aka yi niyya, da ƙaddamar da ɓarna.
2)EDOF ya tsawaita zurfin fasahar filin: Fasahar EDOF da Olympus ta ƙera ta cimma zurfin filin ta hanyar rarraba hasken haske: ana amfani da prisms guda biyu don raba hasken zuwa katako guda biyu, suna mai da hankali kan hotuna na kusa da nesa bi da bi, kuma a ƙarshe suna haɗa su cikin hoto mai haske da m tare da zurfin zurfin filin akan firikwensin. A cikin lura da mucosa na gastrointestinal fili, za a iya gabatar da dukan yanki a fili a fili, yana inganta yanayin gano cutar.
3)Multimodal tsarin hoto
Farashin EVIS X1™tsarin yana haɗa nau'ikan hotuna masu haɓaka da yawa: fasahar TXI: haɓaka ƙimar gano adenoma (ADR) ta 13.6%; Fasaha na RDI: yana haɓaka hangen nesa na jini mai zurfi da wuraren zubar jini; Fasahar NBI: yana inganta lura da tsarin mucosal da jijiyoyin jini; yana canza endoscopy daga "kayan kallo" zuwa " dandamalin ganewar asali ".
6.Yanayin Siyasa da daidaitawar masana'antu
Manufofin da za su shafi masana'antar endoscopy a cikin 2024-2025 sun haɗa da:
Manufar sabunta kayan aiki: Maris 2024 "Tsarin Ayyuka don Haɓaka Sabbin Sabbin Kayayyaki Masu Girma da Maye gurbin Kayayyakin Mabukaci" yana ƙarfafa cibiyoyin kiwon lafiya don haɓaka sabuntawa da sauya kayan aikin hoton likita.
Canjin cikin gida: Manufar 2021 tana buƙatar siyan samfuran gida 100% don laparoscopes na 3D, choledochoscopes, da foramina intervertebral.
Ƙimar haɓakawa: Ana daidaita endoscopes na likita daga Class III zuwa na'urorin likitanci na Class II, kuma an rage lokacin rajista daga fiye da shekaru 3 zuwa shekaru 1-2.
Waɗannan manufofin sun haɓaka ƙirƙira R&D da samun damar kasuwa na endoscopes na cikin gida, ƙirƙirar yanayin ci gaba mai kyau ga masana'antu.
7. Hanyoyin ci gaba na gaba da ra'ayoyin masana
1)Haɗin kai da fasaha
"Fasahar haɗin gwiwa mai iyaka biyu": Laparoscope (hard scope) da endoscope (soft scope) suna aiki tare a cikin tiyata don magance matsalolin asibiti masu rikitarwa.
"Taimakon basirar ɗan adam": Algorithms na AI suna taimakawa wajen gano raunuka da yanke shawara.
Ci gaban kimiyyar kayan abu": Haɓaka sabbin kayan aiki waɗanda suka fi ɗorewa da sauƙin tsaftacewa.
2)Bambance-bambancen kasuwa da haɓakawa
Masana sun yi imanin cewa endoscopes da za a iya zubar da su da kuma sake amfani da endoscopes za su kasance tare na dogon lokaci:
Abubuwan da za a iya zubarwa: dace da yanayin yanayin kamuwa da cuta (kamar gaggawa, likitan yara) da cibiyoyin kiwon lafiya na farko.
Samfuran da za a sake amfani da su: kula da farashi da fa'idodin fasaha a cikin yanayin amfani da yawa a manyan asibitoci.
Binciken Likitan Mole ya nuna cewa ga cibiyoyi masu matsakaicin amfanin yau da kullun sama da raka'a 50, cikakken farashin kayan aikin sake amfani da su ya yi ƙasa.
3)Canjin cikin gida yana hanzari
Kason cikin gida ya karu daga kashi 10% a shekarar 2020 zuwa kashi 26% a shekarar 2022, kuma ana sa ran zai ci gaba da karuwa. A cikin fagagen ƙwanƙolin ƙyanƙyashin ƙyalli da ƙananan ƙwayoyin cuta, fasahar ƙasata ta riga ta ci gaba a duniya. Ƙaddamar da manufofi, "lokaci ne kawai" don kammala maye gurbin gida.
4)Daidaita tsakanin fa'idodin muhalli da tattalin arziki
Endoscopes da za a sake amfani da su na iya rage yawan amfani da albarkatu da kashi 83 cikin 100, amma ana buƙatar magance matsalar jiyya na ruwan sharar sinadarai a cikin tsarin lalata. Bincike da haɓaka kayan da ba za a iya lalata su ba shine muhimmin alkibla a nan gaba.
Tebura: Kwatanta tsakanin abubuwan da za a iya sake amfani da su da kuma zubar da su
| Kwatanta Girma | Maimaituwa Endoscope | Za a iya zubarwa Endoscope |
| Farashin kowane amfani | Ƙananan (Bayan rabo) | Babban |
| Zuba jari na farko | Babban | Ƙananan |
| Ingancin hoto | m
| mai kyau |
| Hadarin kamuwa da cuta | Matsakaici (dangane da ingancin disinfection) | Ƙananan sosai |
| Abotakan muhalli | Matsakaici (samar da ruwan sharar gida) | Talakawa (Sharar Filastik) |
| Abubuwan da suka dace | Amfani mai yawa a manyan asibitoci | Asibitoci na farko/sassan kamuwa da cuta |
Kammalawa: A nan gaba, fasahar endoscopic za ta nuna yanayin ci gaba na "madaidaici, ƙananan cin zarafi, da hankali", kuma endoscopes da za a sake amfani da su har yanzu za su kasance ainihin mai ɗaukar hoto a cikin wannan tsarin juyin halitta.
Mu, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., wani manufacturer ne a kasar Sin ƙware a cikin endoscopic consumables, kamarbiopsy forceps, hemoclip, polyp tarko,allurar sclerotherapy, fesa catheter,cytology goge, jagora, kwandon dawo da dutse, hanci biliary drainage catheter,urethra samun kumfakumaKumburin shiga urethra tare da tsotsada dai sauransu. wadanda ake amfani da su sosai a ciki EMR, ESD, ERCP. Samfuran mu suna da takaddun CE, kuma tsire-tsirenmu suna da takaddun ISO. An fitar da kayanmu zuwa Turai, Arewacin Amurka, Gabas ta Tsakiya da wani yanki na Asiya, kuma suna samun abokin ciniki yabo da yabo!
Lokacin aikawa: Yuli-25-2025